EFTA Document EFTA01971530

To: Jeffrey [email protected]] From: jeffreyepsteinorg©gmail.com on behalf of Sent Tue 6/11/2013 8:29:49 PM Subject Re: an amazing efficacy of brain food.TSH1 ycs will do. On Tue, Jun 11, 2013 at 4:46 AM, Jeffrey Epstein leevaCatiOnAzmail.com> wrote: Get more info On Tuesday, June 11, 2013 wrote: Forwarded messa e From: Tohru Date: Mon, Jun 10, 2013 at 10:31 PM Subject: an amazing efficacy of brain food,TSH I To: jeffeyepsteinorg®gotail.com Dear Jeffrey; Do you know any medicine, drugs can recover the cognitive ability of patient with an advanced stage to active, even normal cognition? Many clinical trials for Alzheimer's patients with earlier, even middle stage are all failed. And scientist said the clinical trial for the patients with severe or middle stage are too late to recover their cognition, because their neurons are almost dead. Is it true? I am now happy to open the non-confidential data to you. You may be surprised at my data. Because my TSH1 can induce the strong recovery process of the sever advanced stage of Alzheimer's disease patients. Especially TSH1 can induce the hippocampal volume recovery in No 1 patient. Now I sincerely request you to support my TSH1 developing. As you know, Alzheimer's disease is known as a non-cure disease, non-treatable disease, but now TSH1 can cure and recover AD cognitive impairment. > EFTA_R1_00454354 EFTA01971530 Sincerely yours Tohru Hasegawa, Ph.D and Prof. The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JetTrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation(agmail.com and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00454355 EFTA01971531